Suppliers / Hisun Pharmaceutical (Hangzhou)

Hisun Pharmaceutical (Hangzhou)

China Updated 9 July 2026

Hisun Pharmaceutical (Hangzhou) is an API manufacturer based in China. It holds 4 valid CEPs across a filed portfolio of 4 molecules.

0
active US DMFs
4
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Hangzhou City, China Not on file

What they file, and where

Molecule Regulators Docs
Everolimus EDQM 1
Moxidectin For Veterinary Use EDQM 1
Mycophenolate Mofetil EDQM 1
Tacrolimus EDQM 1

Also appears on these molecule pages

Mycophenolate Mofetil API Tacrolimus API

Comparing suppliers?

Choose your molecules and target markets. Hisun Pharmaceutical (Hangzhou) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability